![The Lancet in conversation with artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/a7/fb/fa/a7fbfadd-a807-e2ac-b984-3da61842008a/mza_415279516980781336.jpg/100x100bb.jpg)
The Lancet: November 16, 2007
The Lancet in conversation with
English - November 16, 2007 08:00 - 13 minutes - 9.41 MBLife Sciences Science Education medicine research covid diseases science health care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Lancet: November 09, 2007
Next Episode: The Lancet: November 23, 2007
Arne Astrup from the University of Copenhagen, Denmark, discusses a meta-analysis highlighting how the anti-obesity drug rimonabant is associated with an increased risk of depressive disorders. The meta-analysis pooled data from four randomised trials from the RIO (rimonabant in obesity) programme.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv